Publication:
Mechanisms of fibrous cap formation in atherosclerosis.

dc.contributor.authorAlonso-Herranz, Laura
dc.contributor.authorAlbarrán-Juárez, Julián
dc.contributor.authorBentzon, Jacob Fog
dc.contributor.funderNovo Nordisk Foundationes_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)es_ES
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)es_ES
dc.date.accessioned2023-10-17T10:16:20Z
dc.date.available2023-10-17T10:16:20Z
dc.date.issued2023
dc.description.abstractThe fibrous cap is formed by smooth muscle cells that accumulate beneath the plaque endothelium. Cap rupture is the main cause of coronary thrombosis, leading to infarction and sudden cardiac death. Therefore, the qualities of the cap are primary determinants of the clinical outcome of coronary and carotid atherosclerosis. In this mini-review, we discuss current knowledge about the formation of the fibrous cap, including cell recruitment, clonal expansion, and central molecular signaling pathways. We also examine the differences between mouse and human fibrous caps and explore the impact of anti-atherosclerotic therapies on the state of the fibrous cap. We propose that the cap should be understood as a neo-media to substitute for the original media that becomes separated from the surface endothelium during atherogenesis and that embryonic pathways involved in the development of the arteria media contribute to cap formation.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipLA-H is supported by a grant from the Danish Cardiovascular Academy (PD2Y-2022003-DCA), JA-J by a grant from the Aarhus University Research Foundation (Starting Grant, AUFF-E-201 9-7- 23) and JB by grants from the Novo Nordisk Foundation (NNF17OC0030688), Ministerio de Ciencia e Innovación with cofunding from the European Regional Development Fund (PID2019-108568RB-I00), and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 866240). The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MICIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020- 001041-S funded by MICIN/AEI/10.13039/501100011033).es_ES
dc.format.page1254114es_ES
dc.format.volume10es_ES
dc.identifier.citationFront Cardiovasc Med. 2023 Aug 21:10:1254114.es_ES
dc.identifier.doi10.3389/fcvm.2023.1254114es_ES
dc.identifier.issn2297-055Xes_ES
dc.identifier.journalFrontiers in cardiovascular medicinees_ES
dc.identifier.pubmedID37671141es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16577
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MICIN/AEI/10.13039/501100011033/CEX2020-001041-Ses_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/ERC/866240es_ES
dc.relation.publisherversion10.3389/fcvm.2023.1254114es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Patología Experimental de la Aterosclerosises_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleMechanisms of fibrous cap formation in atherosclerosis.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication21dd02b4-c8bc-4bf7-9feb-2dad816e7a02
relation.isAuthorOfPublication.latestForDiscovery21dd02b4-c8bc-4bf7-9feb-2dad816e7a02

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mechanisms of fibrous cap_Front Cardiovasc Med_2023.pdf
Size:
7.55 MB
Format:
Adobe Portable Document Format
Description:
Review